Search

everythinglearnresearchcommunity

for

Search:↓

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Creators of YouTube 'bro-science' baldness videos are driven by a need to share and persuade, often emphasizing authenticity and community building, while navigating trust issues related to commercial ties.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.